fluconazole and clotrimazole

fluconazole has been researched along with clotrimazole in 143 studies

Research

Studies (143)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (2.10)	18.7374
1990's	32 (22.38)	18.2507
2000's	39 (27.27)	29.6817
2010's	63 (44.06)	24.3611
2020's	6 (4.20)	2.80

Authors

Authors	Studies
Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA	1
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA	1
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K	1
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K	1
Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK	1
Brien, JF; Dercho, RA; Kinobe, RT; Nakatsu, K; Szarek, WA; Vlahakis, JZ	1
Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P	1
Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL	1
Colby, DW; Collins, SR; Feng, BY; May, BC; Prusiner, SB; Shoichet, BK; Toyama, BH; Weissman, J; Wille, H	1
Kelly, DE; Kelly, SL; Manning, NJ; Merkamm, M; Parker, JE; Pompon, D	1
Amiri, F; Assadpour, E; Hossaini, Z; Khabnadideh, S; Pakshir, K; Rezaei, Z	1
Jackson, CJ; Kelly, DE; Kelly, SL; Lamb, DC; Marczylo, TH; Parker, JE; Warrilow, AG	1
Pratim Roy, P; Roy, K	1
Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Kelly, DE; Kelly, SL; Martel, CM; Melo, N; Nes, WD; Parker, JE; Warrilow, AG	1
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M	1
Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, NJ; Warrilow, AG	1
Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M	1
Ekins, S; Williams, AJ; Xu, JJ	1
Driscoll, MD; Lafite, P; Levy, C; Leys, D; Mast, N; McLean, KJ; Munro, AW; Pikuleva, IA; Rigby, SE	1
Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; D'Ascenzio, M; Granese, A; Lilli, D; Rivanera, D; Secci, D	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Bizzarri, B; Bolasco, A; Carradori, S; D'Ascenzio, M; Mari, E; Polletta, L; Rivanera, D; Secci, D; Zicari, A	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Kumar, S; Mishra, NN; Shukla, PK; Tandon, VK	1
Bizzarri, B; Bolasco, A; Carradori, S; Lotti, LV; Mari, E; Rivanera, D; Secci, D; Zicari, A	1
Anand, N; Chaturvedi, V; Dwivedi, AK; Gupt, MP; Gupta, V; Kumar, B; Lal, J; Pandey, S; Pandey, SK; Rai, N; Ramachandran, R; Ramakrishna, KK; Sharma, P; Shukla, PK; Singh, S; Srivastava, KK; Tripathi, RP	1
Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S	1
Bharate, SS; Vishwakarma, RA	1
Akdemir, A; Bizzarri, B; Bolasco, A; Caprara, F; Carradori, S; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zicari, A	1
Bai, X; Chen, Y; Jin, L; Lai, R; Liu, W; Lu, Q; Luan, N; Rong, M; Yan, X; Yao, H; Zhang, Z	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Aktumsek, A; Bizzarri, B; Carradori, S; Chimenti, P; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zengin, G; Zicari, A	1
Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N	1
Emami, S; Keighobadi, M; Tavangar, P	1
Bizzarri, B; Carradori, S; D'Ascenzio, M; De Monte, C; Grande, R; Mari, E; Patsilinakos, A; Ragno, R; Rivanera, D; Sabatino, M; Secci, D; Zicari, A	1
de Carvalho, LPS; Gomaa, MS; Helal, MA; Kishk, SM; McLean, KJ; Mostafa, SM; Munro, AW; Salama, I; Simons, C; Sood, S	1
Wang, SQ; Wang, YF; Xu, Z	1
Sun, B; Sun, N; Sun, Y; Tian, L; Zhao, D; Zhao, L; Zhao, S	1
Benhamou, RI; Dorot, O; Elias, R; Fridman, M; Jaber, QZ; Oved, K; Pichinuk, E; Zada, SL	1
Gao, F; Huang, G; Xiao, J	1
Barnett, A; Rowe, BR; Thorpe, J	1
Daujat, M; Domergue, J; Fabre, I; Joyeux, H; Maurel, P; Maurice, M; Pichard, L	1
Georgiev, VS	1
Christensen, S; Mummaw, N; Stein, GE	1
Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM	1
Boag, FC; Houang, ET; Lawrence, AG; McCormack, SM; Westrom, R	1
Fass, RJ; Koletar, SL; Plouffe, JF; Russell, JA	1
Letourneau, RJ; Liss, RH	1
Odds, FC; Webster, CE	1
Bernhardt, R; Denner, K; Doehmer, J; Schmalix, W; Vogel, R	1
Bradley, B; Brooker, D; Sobel, JD; Stein, GE; Thomason, JL; Weinstein, L; Wermeling, DP	1
Carey, J; Eyster, ME; Feinberg, J; Finkelstein, D; Frame, P; He, W; Koletar, SL; Powderly, WG; van der Horst, C; Waskin, H	1
Clumeck, N	1
Greenspan, D	1
Baillie, F; Clink, H; De Vol, EB; Ellis, ME; Ernst, P; Halim, MA; Qadri, SM; Spence, D	1
Bradley, SF; He, X; Kauffman, CA; Ridenour, GL; Sangeorzan, JA; Tiballi, RN; Zarins, LT	1
Euser, R; Merkus, HM; van Heusden, AM; Verhoeff, A	1
Burnie, J; Clink, H; Ellis, ME; Ernst, P; Greer, W; Halim, MA; Hussain Qadri, SM; Kalin, M; Padmos, A; Spence, D	1
Debruin, M; Greenspan, D; Pons, V	1
Glatt, AE	1
Kinghorn, GR; Roy, RB; Soeltz-Szoets, J; Stary, A; Ziegler, C	1
Cuschieri, P; Galizia, AC; Vassallo, J	1
Finkelstein, DM; Schoenfeld, DA; Stamenovic, E	1
Mahé, C	1
Benko, I; Hernádi, F; Kiss, A; Kovács, P; Kraicsovits, F; Megyeri, A; Somogyi, G; Tegyey, Z	1
Finkelstein, DM; Schoenfeld, DA	1
Bouchara, JP; Chabasse, D; Declerk, P; Defontaine, A; Hallet, JN; Planchenault, C	1
Berger, MS; Kohl, TD; Martin, DC	1
Bujdáková, H; Dierich, MP; Gruber, A; Klobusický, M; Kurisková, S; Langgartner, M; Lell, CP; Spötl, L; Würzner, R	1
Brown, P; Jandourek, A; Vazquez, JA	1
Drew, SV; Low, L; Matthews, P	1
Ringdahl, EN	1
Haapasalo, MP; Meurman, JH; Samaranayake, LP; Waltimo, TM; Ørstavik, D	1
Ellepola, AN; Samaranayake, LP	2
Cheng, B	1
Ashbee, HR; Barton, RC; El-Din, SS; Evans, EG; Reynolds, MT	1
Bonito, AJ; Patton, LL; Shugars, DA	1
Crego, AL; Gómez, J; Lavandera, JL; Marina, ML	1
Arzumanyan, VG; Semenov, BF	1
DeFor, TE; Goodman, JL; MacMillan, ML; Weisdorf, DJ	1
Lima, SM; Martins, RS; Mesquita, RA; Péreira, ES; Santos, VR; Senna, MI	1
Abdel-Moety, EM; AbouAl-Alamein, AM; Kelani, KM; Khattab, FI	1
Engelen, M; Rochette, F; Vanden Bossche, H	1
Dabbs, ER; Lephoto, C; Naidoo, S; Nikitina, N	1
Fladung, B; Krauss, C; Mendling, W	1
Retzer, DR	1
Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V	1
Chanana, C; Mittal, S; Raina, U; Sharma, JB	1
Tietz, HJ	1
Barisić, D; Corić, M; Lovrić, H	1
Agyarko-Poku, T; Asamoah-Adu, C; Deslandes, S; Diakité, S; Frost, E; Khonde, N; Labbé, AC; Pépin, J; Sobela, F; Sylla, M	1
Ishida, S; Matsui, H; Nishimura, Y; Okano, Y; Oyama, TB; Oyama, TM; Oyama, Y; Sakanashi, Y; Yokota, S	1
Barker, S; Essmann, M; Larsen, B; Schmidt, M	1
Bachhav, YG; Patravale, VB	1
Rutt, AL; Sataloff, RT	1
Ahn, KJ; Choi, JH; Kim, HW; Kim, KJ; Kim, MN; Kim, NI; Ko, JH; Kye, YC; Lee, JY; Lee, KH; Lee, YW; Park, KC; Ro, YS; Yim, SM	1
Fick, J; Lindberg, RH; Tysklind, M	1
Pai, KM; Rao, S; Sholapurkar, AA	1
Akbari, N; Alborzi, N; Dehghan, M; Keshtkar, AA; Sadani, S	1
Davis, JD; Harper, AL	1
George, AT; Ray, A; Ray, S; Swaminathan, N	1
Grześkowiak, T; Zgoła-Grześkowiak, A	1
Sekhavat, L; Tabatabaii, A; Tezerjani, FZ	1
García-Valcárcel, AI; Tadeo, JL	1
Dominessy, C; Min, D; Oliveira, E	1
Huang, Q; Peng, X; Wang, C; Wang, Z; Yu, Y; Zhang, K	1
Agustí, G; Codony, F; Fittipaldi, M; Morató, J	1
Kelly, DE; Kelly, SL; Parker, JE; Warrilow, AG	1
Fan, S; Li, J; Liu, X; Shan, Y; Zhu, Y	1
Patel, S; Patel, SV	1
Escorial, C; García-Valcárcel, AI; Loureiro, I; Molero, E; Tadeo, JL	1
Goldsmith, P; Nasir, S	1
Fan, S; Guo, X; Li, T; Liang, Y; Liu, X; Zhou, X; Zhu, Y	1
Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AG	1
Araya, I; Camponovo, R; Carrillo-Muñoz, AJ; Cerda, A; Diaz, MC; Santander, MP	1
Bai, HH; Dong, HY; Liu, ZH; Wang, FJ; Wu, WX; Zhang, D	1
Holman, TR; Hughes, DD; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Rolley, NJ; Smyrniotis, CJ; Thoss, V; Warrilow, AG	1
Berta, G; Bona, E; Cantamessa, S; Gamalero, E; Massa, N; Novello, G; Pavan, M; Rocchetti, A	1
Alburquenque, C; Bucarey, S; Díaz, MC; Fortes, P; Hermosilla, G; Magne, F; Rodas, PI; Salinas, H; Tapia, CV	1
Garvey, EP; Hoekstra, WJ; Kelly, DE; Kelly, SL; Nes, WD; Parker, JE; Price, CL; Schotzinger, RJ; Warrilow, AGS; Wiederhold, NP	1
Dhital, S; Kattel, HP; Khadka, S; Khatiwada, S; Mishra, SK; Parajuli, K; Parajuli, N; Pokhrel, BM; Pradhan, M; Rijal, BP; Shah, N; Sharma, S; Sherchand, JB	1
Chen, H; Fang, F; Feng, D; Mei, L; Wang, X; Wei, DM; Xie, HY	1
Dawgul, MA; Grzywacz, D; Kamysz, W; Liberek, B; Myszka, H	1
Abutalebian, S; Bahardoost, M; Daie Ghazvini, R; Elahi, M; Gerami Shoar, M; Hashemi, SJ; Kamali Sarwestani, Z; Mahmoudi, S; Rezaie, S; Tajdini, A	1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E	1
Cianci, A; Corsello, S; Ettore, G; Genovese, C; Mattana, P; Tempera, G	1
Hay, RJ; Jemec, GBE; Saunte, DML; Taudorf, EH	1
Elgaard, C; Kretschmann, AC; Munkboel, CH; Olesen, MK; Rasmussen, TB; Styrishave, B	1
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K	1
Burlaga, N; Kaczorek, E; Pacholak, A	1
Lee, A; Saeed, SR; Tysome, JR	1
Ali, FA; Mohammed, AK; Salh, KK	1
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A	1
Čonková, E; Malinovská, Z; Váczi, P	1

Reviews

20 review(s) available for fluconazole and clotrimazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold. European journal of medicinal chemistry, 2017, Jan-27, Volume: 126 Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines	2017
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase	2017
Tetrazole hybrids and their antifungal activities. European journal of medicinal chemistry, 2019, May-15, Volume: 170 Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles	2019
Strategies for the development of highly selective cytochrome P450 inhibitors: Several CYP targets in current research. Bioorganic & medicinal chemistry letters, 2019, 08-15, Volume: 29, Issue:16 Topics: Animals; Binding Sites; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Development; Heme; Humans; Hydrophobic and Hydrophilic Interactions; Protein Binding	2019
Current scenario of tetrazole hybrids for antibacterial activity. European journal of medicinal chemistry, 2019, Dec-15, Volume: 184 Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles	2019
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs. Respiration; international review of thoracic diseases, 1992, Volume: 59, Issue:5 Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrimazole; Disease Models, Animal; Fluconazole; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Otitis Externa	1992
Treatment of oropharyngeal candidiasis in HIV-positive patients. Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 2 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Clotrimazole; Fluconazole; HIV Infections; Humans; Ketoconazole; Leukocyte Count; Nystatin; Risk Factors	1994
Recurrent vaginal thrush and soreness. The Practitioner, 1999, Volume: 243, Issue:1602 Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Diagnosis, Differential; Family Practice; Female; Fluconazole; Humans; Nystatin; Recurrence; Sexual Partners	1999
Treatment of recurrent vulvovaginal candidiasis. American family physician, 2000, Jun-01, Volume: 61, Issue:11 Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles	2000
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. Dental update, 2000, Volume: 27, Issue:4 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence	2000
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients. Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2001, Volume: 92, Issue:2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome	2001
Oral candidal infections and antimycotics. Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles	2000
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects. Journal of veterinary pharmacology and therapeutics, 2003, Volume: 26, Issue:1 Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs	2003
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection. The Cochrane database of systematic reviews, 2011, Aug-10, Issue:8 Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Lactobacillus; Probiotics; Randomized Controlled Trials as Topic	2011
Probiotics for vulvovaginal candidiasis in non-pregnant women. The Cochrane database of systematic reviews, 2017, 11-23, Volume: 11 Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; Miconazole; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention	2017
Therapeutic tools for oral candidiasis: Current and new antifungal drugs. Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2 Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles	2019
Combined systemic (fluconazole) and topical (metronidazole + clotrimazole) therapy for a new approach to the treatment and prophylaxis of recurrent candidiasis. Minerva ginecologica, 2019, Volume: 71, Issue:4 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Probiotics; Recurrence	2019
Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. Journal of the European Academy of Dermatology and Venereology : JEADV, 2019, Volume: 33, Issue:10 Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Clotrimazole; Drug Therapy, Combination; Evidence-Based Medicine; Fluconazole; Humans; Ketoconazole; Miconazole; Nystatin	2019
Topical azole treatments for otomycosis. The Cochrane database of systematic reviews, 2021, 05-25, Volume: 5 Topics: Administration, Topical; Adult; Antifungal Agents; Bias; Child; Clotrimazole; Cycloheptanes; Fluconazole; Humans; Imidazoles; Miconazole; Otomycosis; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome	2021

Trials

26 trial(s) available for fluconazole and clotrimazole

Article	Year
Safety of fluconazole in women taking oral hypoglycaemic agents. Lancet (London, England), 1992, Jan-25, Volume: 339, Issue:8787 Topics: Administration, Oral; Aged; Aged, 80 and over; Blood Glucose; Clotrimazole; Diabetes Mellitus; Drug Administration Schedule; Female; Fluconazole; Humans; Hypoglycemic Agents; Middle Aged; Vulvovaginitis	1992
Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis. DICP : the annals of pharmacotherapy, 1991, Volume: 25, Issue:6 Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Middle Aged	1991
Comparison of vaginal flora after treatment with a clotrimazole 500 mg vaginal pessary or a fluconazole 150 mg capsule for vaginal candidosis. Genitourinary medicine, 1991, Volume: 67, Issue:3 Topics: Administration, Oral; Bacteria; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Colony Count, Microbial; Female; Fluconazole; Humans; Pessaries; Vagina	1991
Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candidiasis, Oral; Clotrimazole; Fluconazole; Humans	1990
A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial. British journal of obstetrics and gynaecology, 1989, Volume: 96, Issue:2 Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fluconazole; Humans; Imidazoles; Multicenter Studies as Topic; Triazoles	1989
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. American journal of obstetrics and gynecology, 1995, Volume: 172, Issue:4 Pt 1 Topics: Acute Disease; Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Recurrence; United States	1995
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. The New England journal of medicine, 1995, Mar-16, Volume: 332, Issue:11 Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Clotrimazole; Confidence Intervals; Female; Fluconazole; Follow-Up Studies; Humans; Male; Mycoses; Proportional Hazards Models; Prospective Studies	1995
The effect of fluconazole as prophylaxis for neutropenic patients on the isolation of Candida spp. from surveillance cultures. The Journal of antimicrobial chemotherapy, 1994, Volume: 33, Issue:6 Topics: Adult; Bone Marrow Transplantation; Candida; Candidiasis; Clotrimazole; Female; Fluconazole; Hematologic Diseases; Humans; Male; Neutropenia; Prospective Studies	1994
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. The American journal of medicine, 1994, Volume: 97, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Clotrimazole; Drug Resistance, Microbial; Electrophoresis; Fluconazole; HIV Infections; Humans; Karyotyping; Male; Mouth; Prospective Studies; Risk Factors; Treatment Outcome	1994
A randomized, comparative study of a single oral dose of fluconazole versus a single topical dose of clotrimazole in the treatment of vaginal candidosis among general practitioners and gynaecologists. European journal of obstetrics, gynecology, and reproductive biology, 1994, Jun-15, Volume: 55, Issue:2 Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Aged; Candidiasis, Vulvovaginal; Clotrimazole; Family Practice; Female; Fluconazole; Follow-Up Studies; Gynecology; Humans; Middle Aged; Patient Satisfaction	1994
Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13, Issue:1 Topics: Adolescent; Adult; Bone Marrow Transplantation; Clotrimazole; Female; Fluconazole; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Treatment Outcome	1994
Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group. Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:12 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis, Oral; Clotrimazole; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Prospective Studies; Tablets; Treatment Outcome	1993
Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis. Genitourinary medicine, 1996, Volume: 72, Issue:2 Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Balanitis; Candidiasis; Clotrimazole; Fluconazole; Humans; Male; Middle Aged	1996
Combining mortality and longitudinal measures in clinical trials. Statistics in medicine, 1999, Jun-15, Volume: 18, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; Antifungal Agents; Candidiasis; Child; Child, Preschool; Clinical Trials as Topic; Clotrimazole; Dapsone; Didanosine; Drug Therapy, Combination; Fluconazole; Head; Humans; Longitudinal Studies; Pentamidine; Pneumonia, Pneumocystis; Statistics, Nonparametric; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine	1999
Comparison of topical and oral treatments for tinea gladiatorum. Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 1999, Volume: 9, Issue:3 Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Clotrimazole; Drug Administration Schedule; Fluconazole; Follow-Up Studies; Humans; Male; Pilot Projects; Prospective Studies; Tinea; Wrestling	1999
Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. The American journal of medicine, 2002, Apr-01, Volume: 112, Issue:5 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Child; Child, Preschool; Clotrimazole; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Male; Middle Aged; Postoperative Complications	2002
A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses, 2004, Volume: 47, Issue:3-4 Topics: Administration, Intravaginal; Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Single-Blind Method	2004
Comparative efficacy of two regimens in syndromic management of lower genital infections. Archives of gynecology and obstetrics, 2006, Volume: 273, Issue:4 Topics: Administration, Intravaginal; Adult; Anti-Infective Agents, Local; Azithromycin; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Pruritus; Vaginitis	2006
Fluconazole versus 3-day clotrimazole in the treatment of sporadic and recurrent vulvovaginal candidiasis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2006, Volume: 95, Issue:2 Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fluconazole; Humans; Patient Compliance; Secondary Prevention	2006
The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bulletin of the World Health Organization, 2006, Volume: 84, Issue:9 Topics: Adolescent; Adult; Africa, Western; Animals; Anti-Infective Agents; Antifungal Agents; Antitrichomonal Agents; Candida; Child; Clotrimazole; Drug Therapy, Combination; Female; Fluconazole; Humans; Metronidazole; Mycoplasma genitalium; Neisseria gonorrhoeae; Sex Work; Syndrome; Tinidazole; Treatment Outcome; Trichomonas vaginalis; Vaginal Discharge	2006
Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. International journal of pharmaceutics, 2009, Jan-05, Volume: 365, Issue:1-2 Topics: Adhesiveness; Administration, Intravaginal; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Emulsions; Female; Fluconazole; Gels; Humans; Oils; Particle Size; Pilot Projects; Rabbits; Solubility; Surface-Active Agents; Toxicity Tests	2009
Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: a multicentre, randomised, double-blind, phase III trial. Mycoses, 2010, Volume: 53, Issue:6 Topics: Administration, Topical; Adult; Antifungal Agents; Arthrodermataceae; Clotrimazole; Dermatomycoses; Double-Blind Method; Female; Fluconazole; Humans; Male; Middle Aged; Skin; Treatment Outcome	2010
Comparison of efficacy of fluconazole mouthrinse and clotrimazole mouthpaint in the treatment of oral candidiasis. Australian dental journal, 2009, Volume: 54, Issue:4 Topics: Antifungal Agents; Candidiasis, Oral; Chi-Square Distribution; Clotrimazole; Colony Count, Microbial; Female; Fluconazole; Humans; Immunocompromised Host; Male; Mouthwashes; Ointments; Statistics, Nonparametric; Stomatitis, Denture	2009
Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial. The Journal of dermatology, 2010, Volume: 37, Issue:8 Topics: Adult; Antifungal Agents; Clinical Protocols; Clotrimazole; Double-Blind Method; Female; Fluconazole; Humans; Male; Recurrence; Tinea Versicolor; Treatment Outcome; Young Adult	2010
Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. Journal of infection and public health, 2011, Volume: 4, Issue:4 Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Iran; Middle Aged; Prospective Studies; Treatment Outcome	2011
The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses, 2016, Volume: 59, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Follow-Up Studies; Humans; Middle Aged; Tablets; Treatment Outcome; Vagina; Vaginal Creams, Foams, and Jellies; Young Adult	2016

Other Studies

97 other study(ies) available for fluconazole and clotrimazole

Article	Year
ElogPoct: a tool for lipophilicity determination in drug discovery. Journal of medicinal chemistry, 2000, Jul-27, Volume: 43, Issue:15 Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents	2000
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds. Journal of medicinal chemistry, 2001, Jul-19, Volume: 44, Issue:15 Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water	2001
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. Molecular pharmacology, 2002, Volume: 61, Issue:5 Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine	2002
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein. The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:1 Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine	2002
Identification and prediction of promiscuous aggregating inhibitors among known drugs. Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21 Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship	2003
Inhibition of the enzymatic activity of heme oxygenases by azole-based antifungal drugs. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 319, Issue:1 Topics: Animals; Antifungal Agents; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Ketoconazole; Kinetics; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley	2006
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols	2007
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, 2007, Volume: 35, Issue:3 Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase	2007
Small-molecule aggregates inhibit amyloid polymerization. Nature chemical biology, 2008, Volume: 4, Issue:3 Topics: Acetophenones; Animals; Benzopyrans; beta-Lactamase Inhibitors; beta-Lactamases; Clioquinol; Congo Red; Detergents; Flavanones; Mice; Microscopy, Electron, Transmission; Molecular Structure; Molecular Weight; Particle Size; Peptide Termination Factors; Phenolphthaleins; Phthalimides; Prions; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sensitivity and Specificity; Structure-Activity Relationship	2008
Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Antifungal Agents; Azoles; Base Sequence; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; DNA, Fungal; Drug Resistance, Fungal; Genes, Fungal; Humans; Molecular Sequence Data; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Species Specificity; Sterol 14-Demethylase	2008
Design, synthesis, and antifungal activity of triazole and benzotriazole derivatives. European journal of medicinal chemistry, 2009, Volume: 44, Issue:7 Topics: Antifungal Agents; Catalytic Domain; Clotrimazole; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungi; Models, Molecular; Software; Sterol 14-Demethylase; Triazoles	2009
Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Amino Acid Motifs; Amino Acid Sequence; Azoles; Base Sequence; Cloning, Molecular; Conserved Sequence; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Genes, Bacterial; Hydrogen-Ion Concentration; Molecular Sequence Data; Molecular Structure; Molecular Weight; Mycobacterium leprae; Mycobacterium smegmatis; Osmolar Concentration; Recombinant Proteins; Sequence Homology, Amino Acid; Sodium Chloride	2009
Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques. European journal of medicinal chemistry, 2009, Volume: 44, Issue:7 Topics: Algorithms; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Factor Analysis, Statistical; Least-Squares Analysis; Linear Models; Models, Molecular; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Reproducibility of Results	2009
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Expression, purification, and characterization of Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) isoenzymes A and B. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:10 Topics: Amino Acid Sequence; Aspergillus fumigatus; Azoles; Clotrimazole; Drug Resistance, Multiple, Fungal; Fluconazole; Fungal Proteins; Isoenzymes; Itraconazole; Lanosterol; Molecular Sequence Data; Protein Binding; Pyrimidines; Sequence Homology, Amino Acid; Sterol 14-Demethylase; Substrate Specificity; Triazoles; Voriconazole	2010
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole	2010
Complementation of a Saccharomyces cerevisiae ERG11/CYP51 (sterol 14α-demethylase) doxycycline-regulated mutant and screening of the azole sensitivity of Aspergillus fumigatus isoenzymes CYP51A and CYP51B. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11 Topics: Anti-Bacterial Agents; Aspergillus fumigatus; Azoles; Clotrimazole; Cytochrome P-450 Enzyme System; Doxycycline; Ergosterol; Fluconazole; Fungal Proteins; Genetic Complementation Test; Itraconazole; Pyrimidines; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Triazoles; Voriconazole	2010
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans. European journal of medicinal chemistry, 2010, Volume: 45, Issue:11 Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen. The Journal of biological chemistry, 2010, Dec-03, Volume: 285, Issue:49 Topics: Cholesterol; Crystallography, X-Ray; Cytochrome P-450 Enzyme System; Host-Pathogen Interactions; Humans; Hydroxylation; Mycobacterium tuberculosis; Oxidation-Reduction; Protein Structure, Tertiary	2010
Synthesis and biological evaluation of novel 2,4-disubstituted-1,3-thiazoles as anti-Candida spp. agents. European journal of medicinal chemistry, 2011, Volume: 46, Issue:1 Topics: Antifungal Agents; Candida; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Thiazoles	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Synthesis, anti-Candida activity, and cytotoxicity of new (4-(4-iodophenyl)thiazol-2-yl)hydrazine derivatives. European journal of medicinal chemistry, 2012, Volume: 53 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Candida; Cell Survival; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Hydrazines; Microbial Sensitivity Tests	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Micelles catalyzed chemo- and regio-selective one pot and one step synthesis of 2,3,5,6-tetrakis(alkyl and arylsulfanyl)-1,4-benzoquinones and 2,5-diaminosubstituted-1,4-benzoquinones "In-Water" and their biological evaluation as antibacterial and antifun European journal of medicinal chemistry, 2012, Volume: 56 Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Benzoquinones; Catalysis; Cell Line; Dose-Response Relationship, Drug; Escherichia coli; Klebsiella pneumoniae; Mice; Micelles; Microbial Sensitivity Tests; Molecular Structure; Sporothrix; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Trichophyton; Water	2012
Synthesis and cytotoxicity of novel (thiazol-2-yl)hydrazine derivatives as promising anti-Candida agents. European journal of medicinal chemistry, 2013, Volume: 65 Topics: Antifungal Agents; Candida; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrazines; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles	2013
Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents. ACS medicinal chemistry letters, 2013, Oct-10, Volume: 4, Issue:10 Topics:	2013
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents. European journal of medicinal chemistry, 2014, Aug-18, Volume: 83 Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles	2014
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery. Bioorganic & medicinal chemistry letters, 2015, Apr-01, Volume: 25, Issue:7 Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics	2015
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives. European journal of medicinal chemistry, 2016, Jan-01, Volume: 107 Topics: 14-alpha Demethylase Inhibitors; Anti-Bacterial Agents; Antifungal Agents; Candida; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Fungal Proteins; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Small Molecule Libraries; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidines	2016
A Designed Tryptophan- and Lysine/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis. Journal of medicinal chemistry, 2016, Mar-10, Volume: 59, Issue:5 Topics: Animals; Antimicrobial Cationic Peptides; Arginine; Candida albicans; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Fungal; Female; HEK293 Cells; Hemolysis; Humans; Lysine; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tryptophan; Vaginitis	2016
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties. European journal of medicinal chemistry, 2016, Jul-19, Volume: 117 Topics: Antifungal Agents; Antioxidants; Candida; Chelating Agents; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Thiazolidines; Toxicity Tests	2016
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity. European journal of medicinal chemistry, 2017, Nov-10, Volume: 140 Topics: Antifungal Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Thiazolidines	2017
Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1. Bioorganic & medicinal chemistry, 2019, 04-15, Volume: 27, Issue:8 Topics: Antitubercular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipeptides; Drug Design; Humans; Molecular Docking Simulation; Mycobacterium tuberculosis; Peptides, Cyclic; Piperazines; Tuberculosis	2019
Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles. European journal of medicinal chemistry, 2019, Oct-01, Volume: 179 Topics: Antifungal Agents; Azoles; Candida; Cell Survival; Coumarins; Dose-Response Relationship, Drug; HEK293 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Optical Imaging; Structure-Activity Relationship	2019
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1992, Jan-06, Volume: 6, Issue:2 Topics: Blotting, Northern; Cells, Cultured; Clotrimazole; Cytochrome P-450 Enzyme System; Fluconazole; Humans; Imidazoles; Kinetics; Liver; Metronidazole; Miconazole; Microsomes, Liver; Mixed Function Oxygenases; RNA; RNA, Messenger	1992
Treatment of refractory oral candidiasis with fluconazole. A case report. Oral surgery, oral medicine, and oral pathology, 1991, Volume: 71, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clotrimazole; Deglutition Disorders; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Male	1991
Fungispecificity of fluconazole against Candida albicans. Mycopathologia, 1989, Volume: 108, Issue:3 Topics: Candida albicans; Clotrimazole; Female; Fluconazole; Humans; Lactobacillus; Microscopy, Electron; Microscopy, Electron, Scanning; Mouth Mucosa; Mucous Membrane; Species Specificity; Streptococcus; Vagina	1989
Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections. The Journal of antimicrobial chemotherapy, 1988, Volume: 22, Issue:4 Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Clotrimazole; Female; Fluconazole; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Neutrophils; Phagocytosis; Triazoles; Vagina	1988
Drugs for AIDS and associated infections. The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine	1995
Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitors. Pharmacogenetics, 1995, Volume: 5, Issue:2 Topics: Adrenal Glands; Animals; Base Sequence; Cell Line; Cloning, Molecular; Clotrimazole; Cricetinae; Cricetulus; DNA Primers; DNA, Complementary; Fluconazole; Gene Expression; Hydrocortisone; Hydroxylation; Ketoconazole; Kinetics; Metyrapone; Miconazole; Mitochondria; Molecular Sequence Data; Polymerase Chain Reaction; Recombinant Proteins; Restriction Mapping; Spironolactone; Steroid 11-beta-Hydroxylase; Transfection	1995
Primary prophylaxis against opportunistic infections in patients with AIDS. The New England journal of medicine, 1995, Mar-16, Volume: 332, Issue:11 Topics: AIDS-Related Opportunistic Infections; Clotrimazole; Dapsone; Fluconazole; Humans; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination	1995
Therapy for oropharyngeal candidiasis in HIV-infected patients. Journal of acquired immune deficiency syndromes, 1993, Volume: 6, Issue:12 Topics: AIDS-Related Opportunistic Infections; Candidiasis, Oral; Clotrimazole; Fluconazole; HIV Infections; Humans	1993
Mixed pulmonary infection with Nocardia, Candida, methicillin-resistant Staphylococcus aureus, and group D Streptococcus species. Postgraduate medical journal, 1996, Volume: 72, Issue:853 Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Clotrimazole; Drug Therapy, Combination; Fluconazole; Fusidic Acid; Humans; Imipenem; Immunocompromised Host; Male; Methicillin Resistance; Nocardia Infections; Pneumonia; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin	1996
Analysis of multiple failure time data from an AIDS clinical trial. Statistics in medicine, 1997, Apr-30, Volume: 16, Issue:8 Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Clinical Trials, Phase III as Topic; Clotrimazole; Data Interpretation, Statistical; Fluconazole; HIV-1; Humans; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Survival Analysis; Time Factors; Treatment Failure	1997
Analysis of multiple failure time data from an AIDS clinical trial. Statistics in medicine, 1998, Jun-15, Volume: 17, Issue:11 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Clotrimazole; Data Interpretation, Statistical; Fluconazole; Humans; Proportional Hazards Models; Recurrence; Survival Analysis; Treatment Failure	1998
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro. The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5 Topics: Animals; Antifungal Agents; Azoles; Bone Marrow; Cells, Cultured; Clotrimazole; Dose-Response Relationship, Drug; Econazole; Female; Fluconazole; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Inhibitory Concentration 50; Ketoconazole; Macrophages; Male; Mice; Miconazole; Species Specificity; Stem Cells	1999
In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata. Journal of medical microbiology, 1999, Volume: 48, Issue:7 Topics: Antifungal Agents; Azoles; Candida; Candidiasis; Clotrimazole; DNA, Fungal; DNA, Mitochondrial; Drug Resistance, Microbial; Econazole; Electrophoresis, Agar Gel; Fluconazole; Humans; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Polyenes	1999
The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation. FEMS immunology and medical microbiology, 1999, Volume: 26, Issue:1 Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Clotrimazole; Complement C3b; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Fluconazole; Humans; Immunoblotting; Microbial Sensitivity Tests; Nystatin; Receptors, Complement 3b; Rosette Formation; Sheep; Species Specificity; Thiazoles; Tunicamycin	1999
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:6 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluconazole; Fungemia; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged	1999
In vitro susceptibility of Candida albicans isolates from apical and marginal periodontitis to common antifungal agents. Oral microbiology and immunology, 2000, Volume: 15, Issue:4 Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Flucytosine; Humans; Miconazole; Microbial Sensitivity Tests; Periapical Periodontitis; Periodontitis	2000
Preventing opportunistic infections. PI perspective, 1995, Issue:no 16 Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine	1995
Fungal infection overview. Treatment review, 1995, Issue:no 18 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Fluconazole; Histoplasmosis; Humans; Itraconazole; Meningitis, Cryptococcal; Mycoses	1995
An investigation into the pathogenesis of vulvo-vaginal candidosis. Sexually transmitted infections, 2001, Volume: 77, Issue:3 Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Microbial; Female; Fluconazole; Humans; Middle Aged; Recurrence	2001
Application of capillary zone electrophoresis with off-line solid-phase extraction to in vitro metabolism studies of antifungals. Electrophoresis, 2001, Volume: 22, Issue:12 Topics: Acetic Acid; Acetonitriles; Antifungal Agents; Clotrimazole; Drug Stability; Electrophoresis, Capillary; Fluconazole; Humans; Itraconazole; Ketoconazole; Methanol; Microsomes, Liver; Molecular Structure; Molecular Weight; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Solvents; Triazoles; Verapamil; Voriconazole	2001
Drug sensitivity of Candida yeast isolated from patients with allergic diseases. Bulletin of experimental biology and medicine, 2001, Volume: 131, Issue:4 Topics: Antifungal Agents; Candicidin; Candida; Candidiasis; Clotrimazole; Fluconazole; Humans; Hypersensitivity; Microbial Sensitivity Tests; Nitrophenols	2001
Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis. Journal of oral science, 2002, Volume: 44, Issue:1 Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Brazil; Candida albicans; Candidiasis, Oral; Clotrimazole; Complementary Therapies; Drug Resistance, Fungal; Econazole; Ethanol; Fluconazole; HIV Seronegativity; HIV Seropositivity; Humans; Nystatin; Propolis; Solvents; Statistics, Nonparametric	2002
Chromatographic determination of clotrimazole, ketoconazole and fluconazole in pharmaceutical formulations. Farmaco (Societa chimica italiana : 1989), 2002, Volume: 57, Issue:11 Topics: Antifungal Agents; Calibration; Capsules; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Clotrimazole; Densitometry; Fluconazole; Indicators and Reagents; Ketoconazole; Ointments; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet	2002
Pathogenic Nocardia, Rhodococcus, and related organisms are highly susceptible to imidazole antifungals. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:4 Topics: Antifungal Agents; Clotrimazole; Fluconazole; Imidazoles; Miconazole; Microbial Sensitivity Tests; Nocardia; Rhodococcus	2003
Chronic vulvovaginal candidiasis. The New England journal of medicine, 2004, Dec-09, Volume: 351, Issue:24 Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Humans; Remission Induction	2004
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis. Chemotherapy, 2004, Volume: 50, Issue:6 Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes	2004
[Current treatment recommendations in tinea corporis?]. Medizinische Monatsschrift fur Pharmazeuten, 2006, Volume: 29, Issue:7 Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea	2006
Imidazole antifungals, but not triazole antifungals, increase membrane Zn2+ permeability in rat thymocytes Possible contribution to their cytotoxicity. Toxicology, 2008, Jun-27, Volume: 248, Issue:2-3 Topics: Animals; Antifungal Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Chlorides; Clotrimazole; Dose-Response Relationship, Drug; Fluconazole; Imidazoles; Itraconazole; Male; Rats; Rats, Wistar; Structure-Activity Relationship; T-Lymphocytes; Thymus Gland; Triazoles; Zinc Compounds	2008
Effect of commonly used herbicides on the virulence factor CDR1 in Candida albicans. Environmental toxicology and chemistry, 2008, Volume: 27, Issue:11 Topics: Antifungal Agents; Candida albicans; Clotrimazole; Fluconazole; Fungal Proteins; Ketoconazole; Membrane Transport Proteins	2008
Aspergillus otomycosis in an immunocompromised patient. Ear, nose, & throat journal, 2008, Volume: 87, Issue:11 Topics: Antifungal Agents; Aspergillosis; Aspergillus niger; Clotrimazole; Earache; Fluconazole; Humans; Immunocompromised Host; Male; Middle Aged; Tympanic Membrane; Tympanic Membrane Perforation	2008
Screening of antimycotics in Swedish sewage treatment plants--waters and sludge. Water research, 2010, Volume: 44, Issue:2 Topics: Antifungal Agents; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Naphthalenes; Sewage; Sweden; Terbinafine; Waste Disposal, Fluid; Water Pollutants, Chemical	2010
FPIN’s clinical inquiries: treatment of recurrent vulvovaginal candidiasis. American family physician, 2011, Jun-15, Volume: 83, Issue:12 Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Evidence-Based Medicine; Female; Fluconazole; Humans; Itraconazole; Recurrence	2011
The use of a triple quadrupole linear ion trap mass spectrometer with electrospray ionisation for fragmentation studies of selected antifungal drugs. Rapid communications in mass spectrometry : RCM, 2011, Oct-30, Volume: 25, Issue:20 Topics: Antifungal Agents; Clioquinol; Clotrimazole; Fluconazole; Ions; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry	2011
Influence of moisture on the availability and persistence of clotrimazole and fluconazole in sludge-amended soil. Environmental toxicology and chemistry, 2012, Volume: 31, Issue:3 Topics: Agriculture; Antifungal Agents; Clotrimazole; Environmental Monitoring; Fluconazole; Groundwater; Sewage; Soil; Soil Pollutants; Waste Disposal, Fluid; Water	2012
Fluconazole mouthrinse and clotrimazole mouthpaint effective medications for patients with denture stomatitis (UT CAT #802). Texas dental journal, 2011, Volume: 128, Issue:12 Topics: Administration, Buccal; Antifungal Agents; Candidiasis, Oral; Clotrimazole; Fluconazole; Humans; Mouthwashes; Stomatitis, Denture	2011
Distribution, behavior and fate of azole antifungals during mechanical, biological, and chemical treatments in sewage treatment plants in China. The Science of the total environment, 2012, Jun-01, Volume: 426 Topics: Antifungal Agents; Azoles; Biodegradation, Environmental; China; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical	2012
Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment. Applied microbiology and biotechnology, 2013, Volume: 97, Issue:1 Topics: Antifungal Agents; Azides; Candida albicans; Clotrimazole; Colony Count, Microbial; Fluconazole; Matricaria; Microbial Viability; Oils, Volatile; Real-Time Polymerase Chain Reaction; Thymus Plant	2013
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Antifungal Agents; Candida albicans; Clotrimazole; Escherichia coli; Fluconazole; Fungal Proteins; Humans; Itraconazole; Ketoconazole; Kinetics; Lanosterol; NADP; Protein Binding; Pyrimidines; Recombinant Proteins; Species Specificity; Sterol 14-Demethylase; Triazoles; Voriconazole	2013
Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis. Mycopathologia, 2015, Volume: 179, Issue:1-2 Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nystatin; Retrospective Studies	2015
Prediction of the solubility in lipidic solvent mixture: Investigation of the modeling approach and thermodynamic analysis of solubility. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015, Sep-18, Volume: 77 Topics: Clotrimazole; Fluconazole; Lipids; Models, Chemical; Solubility; Solvents; Thermodynamics	2015
Uptake of azoles by lamb's lettuce (Valerianella locusta L.) grown in hydroponic conditions. Ecotoxicology and environmental safety, 2016, Volume: 124 Topics: Antifungal Agents; Chromatography, Liquid; Clotrimazole; Fluconazole; Hydroponics; Plant Leaves; Plant Roots; Tandem Mass Spectrometry; Triazoles; Valerianella	2016
Anogenital allergic contact dermatitis caused by methylchloroisothiazolinone, methylisothiazolinone and topical clotrimazole with subsequent generalized exanthem triggered by oral fluconazole. Contact dermatitis, 2016, Volume: 74, Issue:5 Topics: Adult; Antifungal Agents; Anus Diseases; Clotrimazole; Dermatitis, Allergic Contact; Drug Eruptions; Female; Fluconazole; Humans; Patch Tests; Preservatives, Pharmaceutical; Thiazoles; Vulvar Diseases	2016
The Investigational Drug VT-1129 Is a Highly Potent Inhibitor of Cryptococcus Species CYP51 but Only Weakly Inhibits the Human Enzyme. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Antifungal Agents; Clotrimazole; Cryptococcus; Enzyme Activation; Ergosterol; Fluconazole; Humans; Itraconazole; Ketoconazole; Lanosterol; Pyridines; Sterol 14-Demethylase; Tetrazoles; Voriconazole	2016
[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Nystatin	2016
Species Distribution and In Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China. Chinese medical journal, 2016, May-20, Volume: 129, Issue:10 Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; China; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests	2016
Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa. Scientific reports, 2016, 06-13, Volume: 6 Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Cytochrome P450 Family 51; Drug Evaluation, Preclinical; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Kinetics; Lipids; Malassezia; Spectrophotometry; Sterol 14-Demethylase; Sterols; Voriconazole	2016
Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents? Journal of applied microbiology, 2016, Volume: 121, Issue:6 Topics: Antifungal Agents; Candida; Candida albicans; Clotrimazole; Female; Fluconazole; Humans; Itraconazole; Oils, Volatile	2016
Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis. Mycopathologia, 2017, Volume: 182, Issue:3-4 Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazole; Female; Fluconazole; Genotype; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Young Adult	2017
The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:7 Topics: Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyridines; Sterol 14-Demethylase; Substrate Specificity; Tetrazoles; Trichophyton; Voriconazole	2017
Isolation, speciation and antifungal susceptibility testing of Candida isolates from various clinical specimens at a tertiary care hospital, Nepal. BMC research notes, 2017, Jun-24, Volume: 10, Issue:1 Topics: Antifungal Agents; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Clotrimazole; Cross-Sectional Studies; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nepal; Severity of Illness Index; Tertiary Care Centers	2017
Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates. Medicinal chemistry (Shariqah (United Arab Emirates)), 2018, Volume: 14, Issue:5 Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Diosgenin; Erythrocytes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Saponins	2018
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Clotrimazole; Female; Fluconazole; Fungal Proteins; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Nystatin; Otomycosis; Phylogeny; Polymerase Chain Reaction; Tubulin; Young Adult	2018
The classic azole antifungal drugs are highly potent endocrine disruptors in vitro inhibiting steroidogenic CYP enzymes at concentrations lower than therapeutic Cmax. Toxicology, 2019, 09-01, Volume: 425 Topics: Antifungal Agents; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Clotrimazole; Dose-Response Relationship, Drug; Endocrine Disruptors; Fluconazole; Gas Chromatography-Mass Spectrometry; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Steroid 17-alpha-Hydroxylase	2019
In vitro antifungal activity of luliconazole against nondermatophytic moulds. Medical mycology, 2020, Jul-01, Volume: 58, Issue:5 Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole	2020
Evaluating the Effect of Azole Antifungal Agents on the Stress Response and Nanomechanical Surface Properties of Molecules (Basel, Switzerland), 2020, Jul-23, Volume: 25, Issue:15 Topics: Anti-Bacterial Agents; Azoles; Bacterial Adhesion; Biomechanical Phenomena; Cell Membrane Permeability; Clotrimazole; Epoxy Compounds; Fluconazole; Glutathione; Hydrophobic and Hydrophilic Interactions; Imidazoles; Microbial Sensitivity Tests; Microscopy, Atomic Force; Nanoparticles; Ochrobactrum anthropi; Surface Properties; Triazoles	2020
ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast. Cellular and molecular biology (Noisy-le-Grand, France), 2021, Nov-25, Volume: 67, Issue:3 Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Brucella abortus; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Particle Size; Salmonella typhimurium; Silver; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Titanium; Zinc Oxide	2021
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates. Mycoses, 2022, Volume: 65, Issue:11 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole	2022
Efficacy of manuka honey with conventional antifungals on Polish journal of veterinary sciences, 2023, Volume: 26, Issue:2 Topics: Animals; Antifungal Agents; Azoles; Cat Diseases; Cats; Clotrimazole; Dog Diseases; Dogs; Fluconazole; Honey; Itraconazole; Miconazole	2023